These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9708834)

  • 21. Attention deficit and impulsivity: selecting, shifting, and stopping.
    Kenemans JL; Bekker EM; Lijffijt M; Overtoom CC; Jonkman LM; Verbaten MN
    Int J Psychophysiol; 2005 Oct; 58(1):59-70. PubMed ID: 15950304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attention deficit hyperactivity disorder in sport: a review.
    Corrigan B
    Int J Sports Med; 2003 Oct; 24(7):535-40. PubMed ID: 12968213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Structural and functional neuroanatomy of attention-deficit hyperactivity disorder (ADHD)].
    Emond V; Joyal C; Poissant H
    Encephale; 2009 Apr; 35(2):107-14. PubMed ID: 19393378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional deficits in basal ganglia of children with attention-deficit/hyperactivity disorder shown with functional magnetic resonance imaging relaxometry.
    Teicher MH; Anderson CM; Polcari A; Glod CA; Maas LC; Renshaw PF
    Nat Med; 2000 Apr; 6(4):470-3. PubMed ID: 10742158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The course of behaviour changes in children with attention deficit and hyperactivity after drug treatment].
    Roselló B; Pitarch I; Abad L
    Rev Neurol; 2002 Feb; 34 Suppl 1():S82-90. PubMed ID: 12447796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update.
    Prince J
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S39-45. PubMed ID: 18480676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Collicular dysfunction in attention deficit hyperactivity disorder.
    Overton PG
    Med Hypotheses; 2008; 70(6):1121-7. PubMed ID: 18215471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effects of psychostimulants on the cognitive results and behaviour of children with the combined subtype of attention deficit with hyperactivity].
    Mulas F; Roselló B; Morant A; Hernández S; Pitarch I
    Rev Neurol; 2002 Jul 1-15; 35(1):17-24. PubMed ID: 12389187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Attention deficit hyperactivity disorder in adults: a clinical and therapeutic characterization].
    Ramos-Quiroga JA; Bosch-Munsó R; Castells-Cervelló X; Nogueira-Morais M; García-Gimenez E; Casas-Brugué M
    Rev Neurol; 2006 May 16-31; 42(10):600-6. PubMed ID: 16703528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Working toward a neurobiological account of ADHD: commentary on Gail Tripp and Jeff Wickens, dopamine transfer deficit.
    Williams J
    J Child Psychol Psychiatry; 2008 Jul; 49(7):705-11; discussion 711. PubMed ID: 18598242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulant drug action in attention deficit hyperactivity disorder (ADHD): inference of neurophysiological mechanisms via quantitative modelling.
    Rowe DL; Robinson PA; Gordon E
    Clin Neurophysiol; 2005 Feb; 116(2):324-35. PubMed ID: 15661111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of hyperactivity in children with pervasive developmental disorders.
    Scahill L; Pachler M
    J Child Adolesc Psychiatr Nurs; 2007 Feb; 20(1):59-62. PubMed ID: 17284238
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Lee SI; Hong SD; Kim SY; Kim EJ; Kim JH; Kim JH; Park MK; Park S; Park JH; Oh EY; Lim TS; Cheong S; Cho IH; Choi JW
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):210-6. PubMed ID: 17046131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Misinterpreting emotional expressions in attention-deficit/hyperactivity disorder: evidence for a neural marker and stimulant effects.
    Williams LM; Hermens DF; Palmer D; Kohn M; Clarke S; Keage H; Clark CR; Gordon E
    Biol Psychiatry; 2008 May; 63(10):917-26. PubMed ID: 18272140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
    Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA
    Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advancing the spontaneous hypertensive rat model of attention deficit/hyperactivity disorder.
    Kantak KM; Singh T; Kerstetter KA; Dembro KA; Mutebi MM; Harvey RC; Deschepper CF; Dwoskin LP
    Behav Neurosci; 2008 Apr; 122(2):340-57. PubMed ID: 18410173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attention deficit hyperactivity disorder in children.
    Ramchandani P; Joughin C; Zwi M
    Clin Evid; 2002 Dec; (8):280-90. PubMed ID: 12603883
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hyperactive behavior in adults; possibly attention deficit/hyperactivity disorder (ADHD)].
    Weisfelt M; Schrier AC; de Leeuw MC
    Ned Tijdschr Geneeskd; 2001 Aug; 145(31):1481-4. PubMed ID: 11512417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative analysis of antidepressants and stimulants for the treatment of adults with attention-deficit hyperactivity disorder.
    Higgins ES
    J Fam Pract; 1999 Jan; 48(1):15-20. PubMed ID: 9934377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attention deficit hyperactivity disorder in children.
    Ramchandani P; Joughin C; Zwi M
    Clin Evid; 2002 Jun; (7):262-71. PubMed ID: 12230649
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.